BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26517638)

  • 1. Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.
    Wilmott JS; Field MA; Johansson PA; Kakavand H; Shang P; De Paoli-Iseppi R; Vilain RE; Pupo GM; Tembe V; Jakrot V; Shang CA; Cebon J; Shackleton M; Fitzgerald A; Thompson JF; Hayward NK; Mann GJ; Scolyer RA
    Pathology; 2015 Dec; 47(7):683-93. PubMed ID: 26517638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
    De Paoli-Iseppi R; Johansson PA; Menzies AM; Dias KR; Pupo GM; Kakavand H; Wilmott JS; Mann GJ; Hayward NK; Dinger ME; Long GV; Scolyer RA
    Pathology; 2016 Apr; 48(3):261-6. PubMed ID: 27020503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome characterization in pedigreed non-human primates using genotyping-by-sequencing (GBS) and imputation.
    Bimber BN; Raboin MJ; Letaw J; Nevonen KA; Spindel JE; McCouch SR; Cervera-Juanes R; Spindel E; Carbone L; Ferguson B; Vinson A
    BMC Genomics; 2016 Aug; 17(1):676. PubMed ID: 27558348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
    Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
    Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
    Ganesamoorthy D; Robertson AJ; Chen W; Hall MB; Cao MD; Ferguson K; Lakhani SR; Nones K; Simpson PT; Coin LJM
    BMC Cancer; 2022 Jan; 22(1):85. PubMed ID: 35057759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Genotyping by Digital PCR to Detect and Quantify the BRAF V600E Mutation in Melanoma Biopsies.
    Lamy PJ; Castan F; Lozano N; Montélion C; Audran P; Bibeau F; Roques S; Montels F; Laberenne AC
    J Mol Diagn; 2015 Jul; 17(4):366-73. PubMed ID: 25952101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.
    Bourgon R; Lu S; Yan Y; Lackner MR; Wang W; Weigman V; Wang D; Guan Y; Ryner L; Koeppen H; Patel R; Hampton GM; Amler LC; Wang Y
    Clin Cancer Res; 2014 Apr; 20(8):2080-91. PubMed ID: 24573554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SECEDO: SNV-based subclone detection using ultra-low coverage single-cell DNA sequencing.
    Rozhoňová H; Danciu D; Stark S; Rätsch G; Kahles A; Lehmann KV
    Bioinformatics; 2022 Sep; 38(18):4293-4300. PubMed ID: 35900151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous reference types can confound the detection of somatic mutation in solid cancers.
    Chen X; Zou X; Zhong W; Peng K; Wang D; Fan W; Lin J; Peng J
    DNA Repair (Amst); 2018 Sep; 69():6-13. PubMed ID: 30029072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Genome Sequencing Increases Molecular Diagnostic Yield Compared with Current Diagnostic Testing for Inherited Retinal Disease.
    Ellingford JM; Barton S; Bhaskar S; Williams SG; Sergouniotis PI; O'Sullivan J; Lamb JA; Perveen R; Hall G; Newman WG; Bishop PN; Roberts SA; Leach R; Tearle R; Bayliss S; Ramsden SC; Nemeth AH; Black GC
    Ophthalmology; 2016 May; 123(5):1143-50. PubMed ID: 26872967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of whole genome sequencing from blood versus saliva derived DNA in cardiac patients.
    Yao RA; Akinrinade O; Chaix M; Mital S
    BMC Med Genomics; 2020 Jan; 13(1):11. PubMed ID: 31996208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma.
    Li Y; Bare LA; Bender RA; Sninsky JJ; Wilson LS; Devlin JJ; Waldman FM
    Mol Diagn Ther; 2015 Jun; 19(3):169-77. PubMed ID: 25926090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise detection of de novo single nucleotide variants in human genomes.
    Gómez-Romero L; Palacios-Flores K; Reyes J; García D; Boege M; Dávila G; Flores M; Schatz MC; Palacios R
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5516-5521. PubMed ID: 29735690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI).
    Vanni I; Casula M; Pastorino L; Manca A; Dalmasso B; Andreotti V; Pisano M; Colombino M; ; Pfeffer U; Tanda ET; Rozzo C; Paliogiannis P; Cossu A; Ghiorzo P; Palmieri G;
    Diagn Pathol; 2020 Dec; 15(1):143. PubMed ID: 33317587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating somatic tumor mutation detection without matched normal samples.
    Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
    Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer whole-genome sequencing: present and future.
    Nakagawa H; Wardell CP; Furuta M; Taniguchi H; Fujimoto A
    Oncogene; 2015 Dec; 34(49):5943-50. PubMed ID: 25823020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.
    Kang M; Cho E; Jang J; Lee J; Jeon Y; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Investig Clin Urol; 2019 Jul; 60(4):227-234. PubMed ID: 31294131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.